BioElectronics Drug-free Chronic Pain Therapy Observation Study Results

61% Pain Reduction & Decreases Medication Use in 86% (including opioids) FREDERICK, MD, USA, March 29, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of the drug-free over-the-counter, $30.00 ActiPatch® (www.actipatch.com) Musculoskeletal Pain Therapy medical devices, announced today the completion of a 6-month ActiPatch product observation study conducted in conjunction with its ongoing market … Continue Reading

BioElectronics and B. Braun Medical Ltd Apply for Prescription Payment Clearance on the UK Drug Tariff

FREDERICK, MD. Feb 18, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that B. Braun has initiated the application for a listing of RecoveryRx® on the National Health Service (NHS) drug tariff (http://www.nhsbsa.nhs.uk/PrescriptionServices/4940.aspx).The UK drug tariff list establishes payment for prescription costs in the UK. “Orthopedic surgeons … Continue Reading

BioElectronics Corporation Refutes SEC Order for Administrative Proceedings

FREDERICK, Md., Feb. 8, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that it is responding to a notice of an order for administrative proceedings from the Securities and Exchange Commission posted on the agency website. “Although neither the Company nor any of the respondents have been … Continue Reading

BioElectronics’ Innovative Chronic Pain Therapy Nominated for “Best OTC Marketing Campaign on a Small Budget”

FREDERICK, MD. February 1, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices announced today that its ActiPatch® Musculoskeletal Pain Relief Therapy product received an award nomination from the OTC Bulletin, the leading international trade publication for over-the-counter pharmacy products worldwide for “Best OTC Marketing Campaign on a Small Budget”. The … Continue Reading

BioElectronics Announces Publication of Breakthrough Clinical Study for Drug-free Treatment of Chronic Osteoarthritis

FREDERICK, MD. January 5, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices announced publication of a clinical study demonstrating the efficacy of ActiPatch® Therapy for knee osteoarthritis. This study further validates the positive effects of negating chronic pain central sensitization¹ by ActiPatch® noninvasive neuromodulation therapy. The technology is affordable, effective, … Continue Reading

BioElectronics Announces Oxford University Sponsored Study

ActiPatch® Therapy for Chronic Low Back Pain FREDERICK, MD. Dec 14, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, today announced that Oxford University is sponsoring a clinical trial on chronic lower back pain using ActiPatch® Therapy. Chronic low back pain is a major health problem and has significant … Continue Reading

BioElectronics’ ActiPatch® Pain Therapy Available at 102 Showcase Stores in Canada

FREDERICK, MD. December 7, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that its Canadian distributor, Chris-Kelly LLC, has shipped the initial stocking order to Showcase stores. Chris Russell, President, Chris-Kelly, LLC, stated, “We are excited to have a retail partner like Showcase only eight … Continue Reading

BioElectronics Chairman of the Board Interview

A New Audio Interview With Rick Staelin, Chairman of the Board for BioElectronics Corporation, is Now at SmallCapVoice.com AUSTIN, Texas, Dec. 01, 2015 (GLOBE NEWSWIRE) — SmallCapVoice.com, Inc. (SCV) and BioElectronics Corporation (OTC Pink:BIEL), the maker of advanced consumer pain management medical devices, announced today that a new audio interview with the Company, is now … Continue Reading

BioElectronics’ ActiPatch® Pain Therapy Expands Into Costco Canada

FREDERICK, MD. November 19, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that its Canadian distributor has received its initial orders for its ActiPatch® Pain Relief products from Costco’s online store, http://www.costco.ca/CatalogSearch?storeId=10302&catalogId=11201&langId=-24&refine=&keyword=actipatch. Chris Russell, President, Chris-Kelly, LLC, the Canadian distributor, stated, “This product placement in … Continue Reading

Leading UK Retailer, Superdrug to market and sell ActiPatch® Pain Therapy

FREDERICK, MD. November 9, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that it has received an initial order for its ActiPatch® Musculoskeletal Pain Relief products from Superdrug pharmacies. Superdrug is a subsidiary of the A.S. Watson Group, the world’s largest international health and beauty … Continue Reading